Value Bridge — SWEDISH MEDICAL CENTER
Current $-209M → Target $-178M (+$30.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-208.6M
Current EBITDA
$-178.3M
Target EBITDA
+$30.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.9M
Payer Mix Optimization
$16.5M
Cost to Collect Reduction
$5.5M
Clean Claim Improvement
$4.1M
Volume & Rate Growth
$27.5M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-209M to $-178M. The highest-impact lever is Volume & Rate Growth at $11.0M probability-weighted.
IC talking point: "We see $30M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $334M in equity value creation."